Signaturefd, LLC Nektar Therapeutics Transaction History

Signaturefd, LLC

$4.72 Billion
Q1 2024

A detailed history of Signaturefd, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Signaturefd, LLC holds 200 shares of NKTR stock, worth $234. This represents 0.0% of its overall portfolio holdings.

Number of Shares

200

Previous 200 -0.0%

Holding current value

$234

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$0.42 - $0.57 $1,260 - $1,709	-3,000 Reduced 93.75%	200 $0
Q4 2022 Jan 27, 2023	SELL	$2.03 - $4.28 $3,181 - $6,706	-1,567 Reduced 32.87%	3,200 $7,000
Q3 2022 Nov 08, 2022	SELL	$3.04 - $5.14 $1,447 - $2,446	-476 Reduced 9.08%	4,767 $15,000
Q2 2022 Aug 10, 2022	BUY	$3.17 - $6.17 $1,201 - $2,338	379 Added 7.79%	5,243 $20,000
Q1 2022 May 02, 2022	BUY	$4.16 - $13.72 $3,303 - $10,893	794 Added 19.51%	4,864 $26,000

Q4 2021 Jan 25, 2022	BUY	$10.83 - $18.41 $7,743 - $13,163	715 Added 21.31%	4,070 $55,000
Q3 2021 Oct 28, 2021	BUY	$13.07 - $18.84 $535 - $772	41 Added 1.24%	3,355 $60,000
Q2 2021 Jul 26, 2021	SELL	$16.52 - $20.4 $792 - $979	-48 Reduced 1.43%	3,314 $57,000
Q1 2021 Apr 30, 2021	BUY	$16.56 - $25.46 $794 - $1,222	48 Added 1.45%	3,362 $67,000
Q4 2020 Feb 11, 2021	BUY	$15.77 - $19.03 $1,797 - $2,169	114 Added 3.56%	3,314 $56,000
Q3 2020 Nov 03, 2020	SELL	$16.59 - $24.79 $978 - $1,462	-59 Reduced 1.81%	3,200 $53,000
Q1 2020 Apr 23, 2020	BUY	$14.47 - $27.96 $434 - $838	30 Added 0.93%	3,259 $58,000
Q4 2019 Feb 05, 2020	SELL	$15.87 - $23.12 $2,602 - $3,791	-164 Reduced 4.83%	3,229 $70,000
Q3 2019 Oct 16, 2019	BUY	$16.91 - $36.27 $2,908 - $6,238	172 Added 5.34%	3,393 $62,000
Q2 2019 Jul 31, 2019	BUY	$31.0 - $36.3 $6,665 - $7,804	215 Added 7.15%	3,221 $115,000
Q1 2019 May 09, 2019	SELL	$31.58 - $46.35 $631 - $927	-20 Reduced 0.66%	3,006 $101,000
Q4 2018 Feb 13, 2019	SELL	$30.43 - $56.65 $92,385 - $171,989	-3,036 Reduced 50.08%	3,026 $99,000
Q3 2018 Nov 15, 2018	BUY	$46.46 - $68.49 $279,131 - $411,487	6,008 Added 11125.93%	6,062 $370,000
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $2,358 - $5,326	51 Added 1700.0%	54 $3,000
Q1 2018 May 08, 2018	BUY	$57.4 - $108.44 $172 - $325	3 New	3 $0

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account